All News

Approved by the FDA in July 2018, Perseris is the first once-monthly, subcutaneous risperidone-containing, long-acting injectable available in the United States.

Top news of the day from across the health care landscape.

The new class of smart drugs has the ability to bring the toxic payload directly to the cancer cells.

Continued consumption of peanuts was associated with positive quality of life and perceptions of safety following immunotherapy treatment for peanut allergy.

For this edition of Throwback Thursday, we look back in time at Jonas Salk and his research.

Amazon announced their acquisition of the online pharmacy PillPack, which prides itself on customer service by offering presorted medication, and home delivery, in a press release in June of 2018.

The controlled injection offers patients with plaque psoriasis the ease of self-injection.

The controlled injection offers patients with plaque psoriasis the ease of self-injection.

The findings reinforce the effectiveness of the HPV vaccine in preventing cervical cancer.

Top news of the day from across the health care landscape.

In a real-world setting, long-term outcomes were more favorable following early intensive therapy when compared with first-line moderate-efficacy diseased modifying therapy.

A 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR, Pfizer) used in patients with rheumatoid arthritis increased the risk of blood clots in the lungs and death in a safety clinical trial.

In order for a substantial decrease of HIV infections in the United States, there needs to be a rapid expansion of prevention and treatment for individuals at risk.

Methylprednisolone Tablets had annual sales of approximately $114.3 million in the United States.

Top news of the day from across the health care landscape.

The trial aimed to evaluate the survival rate of patients with metastatic hormone-sensitive prostate cancer who were treated with the combination of enzalutamide and androgen deprivation therapy.

The higher dose is only approved for patients with ulcerative colitis, and not for RA.

A recent study identified genetic changes in e-cigarette users similar to those seen in cigarette smokers.

A survey of sexually active women in the United States revealed that 29% experienced challenges in obtaining either a prescription or a refill for hormonal contraception.

Top news of the day from across the health care landscape.

This study demonstrates the significance and efficacy of breast cancer screenings for prevention and early intervention.

The FDA approved trifluridine/tipiracil (Lonsurf, Taiho Oncology), also known as TAS-102, as a treatment for certain adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

Within the group of Spanish patients with ADHD, a specific variation of the LPHN3 gene increased by 40% the risk of nicotine dependence.

The new loteprednol etabonate ophthalmic gel formulation is expected to be available as a treatment option by April 2019.

The drug showed significant improvement on every primary and secondary endpoint in those who had failed treatment with surgery and/or systemic corticosteroids.

The combination of Opdivo and low-dose Yervoy was compared with sunitinib for a 30-month follow-up.

Study adds to the ongoing research on immunotherapy and its potential as a viable treatment for patients with cancer.

New research supports the use of direct-acting antiviral therapy for all individuals with chronic hepatitis C infection.